These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29382530)

  • 1. Biochemical features of genetic Creutzfeldt-Jakob disease with valine-to-isoleucine substitution at codon 180 on the prion protein gene.
    Ito Y; Sanjo N; Hizume M; Kobayashi A; Ohgami T; Satoh K; Hamaguchi T; Yamada M; Kitamoto T; Mizusawa H; Yokota T
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1055-1061. PubMed ID: 29382530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panencephalopathic Creutzfeldt-Jakob disease with distinct pattern of prion protein deposition in a patient with D178N mutation and homozygosity for valine at codon 129 of the prion protein Gene.
    Marcon G; Indaco A; Di Fede G; Suardi S; Finato N; Moretti V; Micoli S; Fociani P; Zerbi P; Pincherle A; Redaelli V; Tagliavini F; Giaccone G
    Brain Pathol; 2014 Mar; 24(2):148-51. PubMed ID: 24118545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype.
    Peoc'h K; Manivet P; Beaudry P; Attane F; Besson G; Hannequin D; Delasnerie-Lauprêtre N; Laplanche JL
    Hum Mutat; 2000 May; 15(5):482. PubMed ID: 10790216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein.
    Hainfellner JA; Parchi P; Kitamoto T; Jarius C; Gambetti P; Budka H
    Ann Neurol; 1999 Jun; 45(6):812-6. PubMed ID: 10360778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD.
    Pastore M; Chin SS; Bell KL; Dong Z; Yang Q; Yang L; Yuan J; Chen SG; Gambetti P; Zou WQ
    Am J Pathol; 2005 Dec; 167(6):1729-38. PubMed ID: 16314483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 protease resistant prion protein and valine homozygosity at codon 129 of PRNP identify a subtype of sporadic Creutzfeldt-Jakob disease.
    Worrall BB; Herman ST; Capellari S; Lynch T; Chin S; Gambetti P; Parchi P
    J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):671-4. PubMed ID: 10519879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant Creutzfeldt-Jakob disease strain is identical in individuals of two PRNP codon 129 genotypes.
    Diack AB; Boyle A; Plinston C; Hunt E; Bishop MT; Will RG; Manson JC
    Brain; 2019 May; 142(5):1416-1428. PubMed ID: 30938429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy.
    Kovacs GG; Seguin J; Quadrio I; Höftberger R; Kapás I; Streichenberger N; Biacabe AG; Meyronet D; Sciot R; Vandenberghe R; Majtenyi K; László L; Ströbel T; Budka H; Perret-Liaudet A
    Acta Neuropathol; 2011 Jan; 121(1):39-57. PubMed ID: 20593190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development.
    Mitrová E; Belay G
    Acta Virol; 2002; 46(1):31-9. PubMed ID: 12197632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effect of Val
    Fernández-Borges N; Espinosa JC; Marín-Moreno A; Aguilar-Calvo P; Asante EA; Kitamoto T; Mohri S; Andréoletti O; Torres JM
    Emerg Infect Dis; 2017 Sep; 23(9):1522-1530. PubMed ID: 28820136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological progression of genetic Creutzfeldt-Jakob disease with a PrP V180I mutation.
    Akagi A; Iwasaki Y; Mimuro M; Kitamoto T; Yamada M; Yoshida M
    Prion; 2018 Jan; 12(1):54-62. PubMed ID: 29264994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
    Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
    Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative Disorders.
    Lee SM; Chung M; Hyeon JW; Jeong SW; Ju YR; Kim H; Lee J; Kim S; An SS; Cho SB; Lee YS; Kim SY
    PLoS One; 2016; 11(6):e0157540. PubMed ID: 27341347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene.
    Di Fede G; Catania M; Atzori C; Moda F; Pasquali C; Indaco A; Grisoli M; Zuffi M; Guaita MC; Testi R; Taraglio S; Sessa M; Gusmaroli G; Spinelli M; Salzano G; Legname G; Tarletti R; Godi L; Pocchiari M; Tagliavini F; Imperiale D; Giaccone G
    Acta Neuropathol Commun; 2019 Jan; 7(1):1. PubMed ID: 30606247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes.
    Muñoz-Nieto M; Ramonet N; López-Gastón JI; Cuadrado-Corrales N; Calero O; Díaz-Hurtado M; Ipiens JR; Ramón y Cajal S; de Pedro-Cuesta J; Calero M
    J Neurol; 2013 Jan; 260(1):77-84. PubMed ID: 22763467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.
    Parchi P; Castellani R; Capellari S; Ghetti B; Young K; Chen SG; Farlow M; Dickson DW; Sima AA; Trojanowski JQ; Petersen RB; Gambetti P
    Ann Neurol; 1996 Jun; 39(6):767-78. PubMed ID: 8651649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new point mutation in the prion protein gene at codon 210 in Creutzfeldt-Jakob disease.
    Ripoll L; Laplanche JL; Salzmann M; Jouvet A; Planques B; Dussaucy M; Chatelain J; Beaudry P; Launay JM
    Neurology; 1993 Oct; 43(10):1934-8. PubMed ID: 8105421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic background of human prion diseases].
    Kovács GG
    Ideggyogy Sz; 2007 Nov; 60(11-12):438-46. PubMed ID: 18198790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.